Sentences with phrase «plasma cell neoplasms»

Multiple myeloma and other plasma cell neoplasms (cancers) are diseases in which the body makes too many plasma cells.
Bortezomib, carfilzomib, and ixazomib are proteasome inhibitors used in the treatment of multiple myeloma and other plasma cell neoplasms.
Daratumumab and elotuzumab are monoclonal antibodies used in the treatment of multiple myeloma and other plasma cell neoplasms.
The following types of plasma cell neoplasms are cancer:
Plasma cell neoplasms are most common in people who are middle aged or older.
For more information from the National Cancer Institute about multiple myeloma and other plasma cell neoplasms, see the following:
Panobinostat is an HDAC inhibitor used in the treatment of multiple myeloma and other plasma cell neoplasms.
Plasma cell neoplasms are diseases in which abnormal plasma cells or myeloma cells form tumors in the bones or soft tissues of the body.
Several types of targeted therapy may be used to treat multiple myeloma and other plasma cell neoplasms.
Supportive care is given to treat problems caused by multiple myeloma and other plasma cell neoplasms.
Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late - stage differentiation of normal B cells.
In this type of plasma cell neoplasm, less than 10 % of the bone marrow is made up of abnormal plasma cells and there is no cancer.
a b c d e f g h i j k l m n o p q r s t u v w x y z